Welcome to The Leftist Review

Please join our discussion community.

You must log in to your account to leave comments. If you do not have an account, simply register and begin posting comments on articles now. To register, you will need to create a user name and provide a valid email address. Your privacy is guaranteed--your email and information will never be shared. Your password will be sent to your registered email. Thank you!

Member Login
Lost your password?
Not a member yet? Sign Up!

Medicine

The Miracle Money Making Vest

By
January 28, 2016
Defibrillator

For the past fifteen years Zoll Medical has done a remarkable job selling their wearable defibrillator and has certainly created a perfect name for it: The LifeVest. Too many local news agencies, who commonly neglect performing adequate research into their stories, have in essence promoted Zoll’s product as a lifesaver – and too often...

Selling Ranexa: A Prescription for Profiteering?

By
October 27, 2015
Prescription Profiteering

In 2012 alone drug companies spent about 24 billion dollars marketing directly to health care providers, with nine out of the ten largest pharmaceutical companies spending more for marketing than research.

A Visit to the Emergency Room – $$$

By
August 13, 2015
Emergency Room

A doctor’s wife, let's call her Mrs. P, fell after stumbling on some broken asphalt in their driveway. She called her husband when she realized she had injured herself and would not be able to walk back to her home or to their car.

Cheating the Gold Standard in Drug Trials

By
June 21, 2015
Drug Trials

Randomized control trials (RCT) are complex and very expensive studies required by regulatory agencies, in this case the FDA, before a prescription drug is allowed to be touted for its benefits and marketed.  The cost of a single trial, often with thousands of patients enrolled at as much as $5,000 per patient (payments are...

A Dark Cloud Still Lingers Over Sunshine Act

By
April 3, 2015
Medical Industry Payoffs

George Orwell, the inventor of the Ministry of Truth, could not have coined a more biting and sarcastic title than the Sunshine Act. With the advance of the Affordable Care Act the Physician Payments Sunshine Act (now known as Open Payments) could certainly create a dark cloud over every physician who accepted any funding, even...

An Emergency Room Visit: A Game of Chance

By
January 31, 2015
Emergency Room sign

Unfortunately, your first encounter with a hospital is very often in the emergency department or, as it is more familiarly known, the emergency room. You may have a broken arm or a bad cut, you may have burned yourself cooking pasta at the stove or worse, your young child may have swallowed some potentially...

Brisdelle: New Menopause Drug or Alchemy?

By
October 11, 2014
Menopause

In 2013, the FDA finally approved a drug without estrogen for the treatment of menopausal symptoms. When compared to placebo, a study shows that Brisdelle significantly diminished the number of hot flashes in women who took the drug for at least four weeks and for as long as three months. To many it appears...

Throwing Away Billions: Our Broken Healthcare

By
August 19, 2014
Broken Healthcare

If you blame Obamacare for the awful defects in our healthcare system, you are indeed naïve, since any cost-effectiveness or fairness in our system disintegrated long before Barack Obama, or even George W, came to office. I am not a partisan person. I have voted as often for a Republican candidate as for a...

What Televangelists & Alternative Medicine Proponents Have in Common

By
July 21, 2014
Supplements

To the skeptical, Andrew Weil, Mehmet Oz, Joe Mercola, and Deepak Chopra, have an unsavory commonality with people like Jimmy Swaggart, Benny Hinn, and “The Reverend" Jim Bakker. They all offer tales of miraculous healings while peddling something seemingly too good to be true.

How to Charge 40 Billion Dollars for Nothing

By
June 24, 2014
Medical gambling and risk concept for chance, choice, healthcare

In 2002, Merck Labs received FDA approval for the use of their soon-to–be blockbuster drug; a drug that has since given Merck more than $40,000,000,000 (40 billion dollars) in sales. But...



Archive